carbamates has been researched along with Autoimmune Diabetes in 5 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Repaglinide is a novel prandial glucose regulator (PGR) for the treatment of type 2 diabetes." | 2.69 | Bioavailability of repaglinide, a novel antidiabetic agent, administered orally in tablet or solution form or intravenously in healthy male volunteers. ( Hatorp, V; Oliver, S; Su, CA, 1998) |
| "Type 2 diabetes mellitus is a chronic disease with potentially devastating long-term complications." | 1.33 | Oral agents in managing diabetes mellitus in children and adolescents. ( Jacobson-Dickman, E; Levitsky, L, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Østergård, T | 1 |
| Degn, KB | 1 |
| Gall, MA | 1 |
| Carr, RD | 1 |
| Veldhuis, JD | 1 |
| Thomsen, MK | 1 |
| Rizza, RA | 1 |
| Schmitz, O | 1 |
| Ionescu-Tîrgovişte, C | 1 |
| Guja, C | 1 |
| Ioacără, S | 1 |
| Dumitrescu, D | 1 |
| Tomescu, I | 1 |
| Jacobson-Dickman, E | 1 |
| Levitsky, L | 1 |
| Hatorp, V | 1 |
| Oliver, S | 1 |
| Su, CA | 1 |
| Chowdhury, TA | 1 |
| Lasker, SS | 1 |
2 trials available for carbamates and Autoimmune Diabetes
| Article | Year |
|---|---|
The insulin secretagogues glibenclamide and repaglinide do not influence growth hormone secretion in humans but stimulate glucagon secretion during profound insulin deficiency.
Topics: Blood Glucose; C-Peptide; Carbamates; Diabetes Mellitus, Type 1; Fatty Acids, Nonesterified; Glucago | 2004 |
Bioavailability of repaglinide, a novel antidiabetic agent, administered orally in tablet or solution form or intravenously in healthy male volunteers.
Topics: Administration, Oral; Adolescent; Adult; Area Under Curve; Biological Availability; Carbamates; Cros | 1998 |
3 other studies available for carbamates and Autoimmune Diabetes
| Article | Year |
|---|---|
Continuous glucose monitoring: physiologic and pathophysiologic significance.
Topics: Adolescent; Adult; Biomarkers; Blood Glucose; Blood Glucose Self-Monitoring; Carbamates; Circadian R | 2004 |
Oral agents in managing diabetes mellitus in children and adolescents.
Topics: Administration, Oral; Adolescent; Carbamates; Child; Clinical Trials as Topic; Diabetes Mellitus, Ty | 2005 |
Subclinical type 1 diabetes.
Topics: Adult; Blood Glucose; Carbamates; Diabetes Mellitus, Type 1; Female; Glucose Tolerance Test; Humans; | 2002 |